• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, June 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

CooperVision expands plastic neutral initiative in Australia and New Zealand

by rhiannon bowman
May 2, 2023
in Business, Company updates & acquisitions, Local, News
Reading Time: 3 mins read
A A
In 2023, CooperVision has committed to stopping more than 120 million plastic bottles from entering the ocean.

In 2023, CooperVision has committed to stopping more than 120 million plastic bottles from entering the ocean.

Share on FacebookShare on Twitter

CooperVision has announced it is expanding its plastic neutrality initiative, with its full range of contact lenses distributed in Australia and New Zealand now plastic neutral.

The company said the decision to expand the initiative will provide an easy way for eyecare professionals and their patients to be more sustainable in their business and lifestyle.

“The initiative is made possible through a breakthrough global partnership with Plastic Bank, a social enterprise that builds ethical recycling ecosystems in coastal communities,” CooperVision said.

For every box of CooperVision contact lenses distributed in Australia and New Zealand, CooperVision purchases credits that fund the collection and recycling of ocean-bound plastic into the global supply chain, that is equal to the weight of the plastic used in its contact lenses, the blister and the outer carton packaging.

All CooperVision contact lens brands sold and distributed in Australia and New Zealand are included in the plastic neutral initiative, including MyDay, Biofinity, clariti 1 day, MiSight 1 day, Proclear, and cAIR.

There is no enrolment process for eyecare professionals or consumers; anyone who recommends or wears the lenses is participating.

Plastic Bank collectors in the coastal communities receive a premium for the materials they collect, which helps them provide basic family necessities such as groceries, cooking fuel, school fees, and health insurance.

General Manager ANZ, Ms Michelle North, said CooperVision, like many companies, is on a sustainability journey.

Michelle North.

“Over the past several years, we have built a strong track record of sustainable manufacturing and operations, focused on areas in which we can make the greatest impact,” she said.

“Plastic plays a critical role in the hygienic delivery and sterile protection of our contact lenses, and the commitment to making all of our contact lenses in Australia and New Zealand plastic neutral provides the opportunity to make even more of a positive impact — for our oceans, and for everyone.”

Research shows that sustainability is a growing priority for consumers, and they care how plastic is managed. In a 2021 survey commissioned by CooperVision, 94% of contact lens wearers agreed that keeping plastic out of the oceans is important to them. The overwhelming majority (99%) of contact lens wearers agree that if their optometrist recommended a plastic neutral daily disposable contact lens, it would have a positive impact on trying that lens.

Through the partnership with Plastic Bank, the program has already made a significant environmental and social impact worldwide. According to CooperVision, in 2022 the program recovered the equivalent of over 100 million plastic bottles from reaching oceans. It said 345 coastal communities have directly benefited from exchanging ocean-bound plastic for necessities such as clean water, groceries, cooking oil, school tuition, and even health insurance.

In 2023, CooperVision has committed to stopping more than 120 million plastic bottles from entering the ocean in collaboration with Plastic Bank. An online dashboard provides a live update of the program’s impact.

More reading

CooperVision further expands parameters for MyDay toric contact lenses

CooperVision celebrates plastic neutrality milestone

CooperVision ANZ plastic neutrality initiative recognised at national awards

Related Posts

Cyber attackers are often driven by financial gain, with healthcare practices considered a lucrative target. Image: Lee Charlie/Shutterstock.com.

Don’t be blindsided by a cyber attack

by Staff Writer
June 24, 2025

Interruptions to service delivery and reputational damage are consequences of cyber attacks, which means cyber security should be a top...

Optometrist Michael Young’s daughter, a fourth-year optometry student at QUT, undergoing a visual field test on the VF2000 NEO. Image: Michael Young.

Perimetry remastered with VR device from BOC Instruments

by Staff Writer
June 24, 2025

A Californian-made virtual-reality visual field device has been on the wish list of many Australian optometry practice owners thanks to...

The 2025 meeting is taking place in Melbourne 14-17 November. Image: f11photo/stock.adobe.come & Prime Creative Media.

RANZCO has sights on biggest congress yet in 2025

by Staff Writer
June 24, 2025

RANZCO is anticipating its 2025 congress in Melbourne may be one of the largest yet. Since opening registration on 10...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited